Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma

• Grzegorz S. Nowakowski,
• Annalisa Chiappella,
• Thomas E. Witzig,
• David W. Scott,
• Michele Spina,
• Randy D. Gascoyne,
• Lei Zhang,
• Jacqueline Russo,
• Janet Kang,
• Jingshan Zhang,
• Yingyong Xu,
• Umberto Vitolo

Affiliations

Grzegorz S. Nowakowski

Division of Hematology, Mayo Clinic, Rochester, MN, USA

Annalisa Chiappella

Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy

Thomas E. Witzig

Division of Hematology, Mayo Clinic, Rochester, MN, USA

David W. Scott

Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada

Michele Spina

Division of Medical Oncology A, National Cancer Institute, Aviano, Italy

Randy D. Gascoyne

Division of Hematology, Mayo Clinic, Rochester, MN, USA;Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada

Lei Zhang

Celgene Corporation, Summit, NJ; USA

Jacqueline Russo

Celgene Corporation, Summit, NJ; USA

Janet Kang

Celgene Corporation, Summit, NJ; USA

Jingshan Zhang

Celgene Corporation, Summit, NJ; USA

Yingyong Xu

Celgene Corporation, Summit, NJ; USA

Umberto Vitolo

Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy